Monthly Archives: March 2010

Turn Everyday Shopping Into Everyday Giving

What would you do if we told you that every time you shopped online you were helping the work of the Ovarian Cancer National Alliance in our effort to advance the interests of women with ovarian cancer? Well, it’s true. … Continue reading 

Posted in Blog | Leave a comment

Patents On Breast Cancer Genes Ruled Invalid In ACLU/PubPat Case

(ACLU Press Release) MARCH 29, 2010 NEW YORK – Patents on genes associated with hereditary breast and ovarian cancer are invalid, ruled a New York federal court today. The precedent-setting ruling marks the first time a court has found patents … Continue reading 

Posted in News | Leave a comment

Tamoxifen for relapse of ovarian cancer

BACKGROUND: Tamoxifen is an important drug for treating breast cancer. Ovarian cancer cells are known to possess receptors for hormones and may thus also respond to tamoxifen. OBJECTIVES: Tamoxifen is used to treat breast cancer in women whose tumours have … Continue reading 

Posted in Blog, News | Tagged , , , , | Leave a comment

Marti Hughes

Hughes, Marti

My “journey” began on November 1st, 2005 following my radical hysterectomy. I was told I had stage 3 ovarian cancer. I had the usual six cycles of carbo/taxol and surgery number two on January of 2007 followed by IP/IV chemo. … Continue reading 

Posted in Personal stories | Leave a comment

OU doctor leads treatment study for ovarian cancer

A doctor at the OU Health Sciences Center and OU Cancer Institute is directing a nationwide clinical trial to study treatments for ovarian cancer. Dr. Joan Walker, gynecologic oncologist, is leading the trial for the Gynecological Oncology Group. The trial … Continue reading 

Posted in News | Tagged , , , | Leave a comment

Survivors on set at Tristar Products, Inc.

By Jaimie Griffin What a busy week! Georgi and I just got back from Fairfield, New Jersey where we were so excited to have been a part of the production of some brand new ovarian cancer public service announcements. Eight … Continue reading 

Posted in Blog | 1 Comment

Carolyn Adams

My name is Carolyn and I’m fixin’ to turn 43 on April 1st. In April of 2006 I was first diagnosed with stage III ovarian cancer. I took eight rounds of chemo, had a hysterectomy and went into remission. October … Continue reading 

Posted in Personal stories | Leave a comment

Ovarian Cancer National Alliance participated in health reform event

Today, President Obama held a health reform event for health care advocates after the signing of the historic health reform bill.  The Ovarian Cancer National Alliance attended the event, at which Vice President Biden and President Obama spoke.  The President … Continue reading 

Posted in Blog | Tagged , , , , , | Leave a comment

More study needed on vitamin D-ovarian cancer link

There isn’t enough evidence to back or debunk the claim that vitamin D can help reduce the risk of ovarian cancer, despite several recent studies making this claim, the authors of a new review of the scientific literature conclude. Health … Continue reading 

Posted in News | Tagged , , , | 2 Comments

UPDATES: Senate Dear Colleague letter for Ovarian Cancer Research Program

On this page, we will be providing updates of which Senators have signed onto the Dear Colleague letter requesting $30 million to be allocated to the Department of Defense’s Ovarian Cancer Research Program in FY 2011. NEW: View final letter … Continue reading 

Posted in Blog | Tagged , , | 1 Comment

What does Health Reform Mean to Us?

The Ovarian Cancer National Alliance welcomes the improvements contained in the health insurance reform bill that was passed by Congress late Monday, March 22nd.  For years, women with ovarian cancer have had to fight not only the disease, but to … Continue reading 

Posted in News | Tagged , , , , , , , | Leave a comment

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment (Gynecol Oncol)

OBJECTIVES: Ovarian cancer remains a major health problem for women. Although there is considerable clinico-pathological heterogeneity, the molecular genetic basis of ovarian cancer remains poorly understood. Recently, high-resolution genomic maps generated by genome-wide SNP analyses and novel sequencing technologies, have … Continue reading 

Posted in News | Tagged | Leave a comment